Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit

References

• Australian Institute of Health and Welfare and Australasian Association of Cancer Registries 2012Cancer in Australia: an overview, 2012Australian Cancer Incidence and Mortality Workbooks Melanoma Cancer series no 74 Catalog number CAN 70Canberra AustraliaAustralian Institute of Health and Welfare2012
   Google Scholar
• FranckenABAccorttNAShawHMPrognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanomaAnn Surg Oncol2008151476148418196345
   PubMed Web of Science ®Google Scholar
• CreechOJrKrementzETRyanRFChemotherapy of melanoma of the extremities by isolated perfusionCancer Chemother Rep19621657958113882088
   PubMedGoogle Scholar
• HayesAJNeuhausSJClarkMAThomasJMIsolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcomaAnn Surg Oncol20071423023817066234
   PubMed Web of Science ®Google Scholar
• KnorrCMeyerTJanssenTHyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patientsEur J Surg Oncol20063222422716289716
   PubMed Web of Science ®Google Scholar
• NoordaEMVrouenraetsBCNiewegOEKroonBBIsolated limb perfusion in regional melanomaSurg Oncol Clin N Am20061537338416632221
   PubMed Web of Science ®Google Scholar
• TakkenbergRBVrouenraetsBCvan GeelANPalliative isolated limb perfusion for advanced limb disease in stage IV melanoma patientsJ Surg Oncol20059110711116028280
   PubMed Web of Science ®Google Scholar
• AloiaTAGrubbsEOnaitisMPredictors of outcome after hyperthermic isolated limb perfusion: role of tumor responseArch Surg20051401115112016301451
   PubMedGoogle Scholar
• ThompsonJFHuntJAShannonKFKamPCFrequency and duration of remission after isolated limb perfusion for melanomaArch Surg19971329039079267277
   PubMed Web of Science ®Google Scholar
• ReintgenMReintgenCNoboCGiuliano ShiversRSReintgenDRegional therapy for recurrent metastatic melanoma confined to the extremity: hyperthermic isolated limb perfusion vs isolated limb infusionCancers201224350
   Google Scholar
• DerooseJPEggermontAMvan GeelANVerhoefCIsolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alphaCurr Opin Oncol20112318318821150602
   PubMed Web of Science ®Google Scholar
• TestoriAVerhoefCKroonHMTreatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusionJ Surg Oncol201110439740421858835
   PubMed Web of Science ®Google Scholar
• VrouenraetsBCKroonBBNiewegOEThompsonJFIsolated limb perfusion for melanoma: results and complicationThompsonJFMortonDLKroonBBTextbook of MelanomaLondon, UKMartin Dunitz2004
   Google Scholar
• KoopsHSVagliniMSuciuSProphylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organiation Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593J Clin Oncol199816290629129738557
   PubMed Web of Science ®Google Scholar
• ThompsonJFKamPCWaughRCHarmanCRIsolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusionSemin Surg Oncol1998142382479548607
   PubMed Web of Science ®Google Scholar
• LindnerPDoubrovskyAKamPCThompsonJFPrognostic factors after isolated limb infusion with cytotoxic agents for melanomaAnn Surg Oncol2002912713611888868
   PubMed Web of Science ®Google Scholar
• KroonHMMoncrieffMKamPCThompsonJFOutcomes following isolated limb infusion for melanoma. A 14-year experienceAnn Surg Oncol2008153003301318509706
   PubMed Web of Science ®Google Scholar
• KroonHMThompsonJFIsolated limb infusion: a reviewJ Surg Oncol200910016917719365813
   PubMed Web of Science ®Google Scholar
• WieberdinkJBenckhuysenCBraatRPDosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEur J Cancer Clin Oncol1982189059106891640
   PubMedGoogle Scholar
• World Health OrganizationWHO Handbook for Reporting Results of Cancer TreatmentGeneva SwitzerlandWorld Health Organization1979
   Google Scholar
• BalchCMBuzaidACSoongSJFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin Oncol2001193635364811504745
   PubMed Web of Science ®Google Scholar
• TestoriAFariesMBThompsonJFLocal and intralesional therapy of in-transit melanoma metastasesJ Surg Oncol201110439139621858834
   PubMed Web of Science ®Google Scholar
• HongAFogartyGRole of radiation therapy in cutaneous melanomaCancer J20121820320722453022
   PubMed Web of Science ®Google Scholar
• ChapmanPBHauschildARobertCImproved survival with vemurafenib in melanoma with BRAF V600E mutationN Engl J Med20113642507251621639808
   PubMed Web of Science ®Google Scholar
• SosmanJAKimKBSchuchterLSurvival in BRAF V600-mutant advanced melanoma treated with vemurafenibN Engl J Med201236670771422356324
   PubMed Web of Science ®Google Scholar
• BeasleyGMCaudleAPetersenRPA multi-institutional experience of isolated limb infusion: defining response and toxicity in the USJ Am Coll Surg200920870671519476821
   PubMed Web of Science ®Google Scholar
• DupratNeto JPMauroACMolinaASIsolated limb infusion with hyperthermia and chemotherapy for advanced limb malignancy: factors influencing toxicityANZ J Surg9242012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• KroonHMLinDYKamPCThompsonJFEfficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanomaCancer20091151932194019288571
   PubMed Web of Science ®Google Scholar
• LassauNChamiLChebilMDynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatmentsDiscov Med201111182421276407
   PubMed Web of Science ®Google Scholar
• CoventryBJAshdownMLComplete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translationCancer Manag Res2012413714922740774
   PubMedGoogle Scholar
• ThompsonJFHerseyPWachterEChemoablation of metastatic melanoma using intralesional rose bengalMelanoma Res20081840541118830132
   PubMed Web of Science ®Google Scholar
• FooteMCBurmeisterBHThomasJMark SmithersBA novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case seriesMelanoma Res201020485120009957
   PubMed Web of Science ®Google Scholar
• ShafrenDRAuGGNguyenTSystemic therapy of malignant human melanoma tumors by a common cold-producing virus, coxsackievirus A21Clin Cancer Res200410536014734451
   PubMed Web of Science ®Google Scholar
• DamianDLShannonKFSawRPThompsonJFTopical diphencyprone immunotherapy for cutaneous metastatic melanomaAustralasian Journal of Dermatology20095026627119916970
   PubMed Web of Science ®Google Scholar